Redox-Regulation in Cancer Stem Cells

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Oct 27

PMID 36289675

Authors

Uwe Lendeckel

Carmen Wolke

Affiliations

Soon will be listed here.

Abstract

Cancer stem cells (CSCs) represent a small subset of slowly dividing cells with tumor-initiating ability. They can self-renew and differentiate into all the distinct cell populations within a tumor. CSCs are naturally resistant to chemotherapy or radiotherapy. CSCs, thus, can repopulate a tumor after therapy and are responsible for recurrence of disease. Stemness manifests itself through, among other things, the expression of stem cell markers, the ability to induce sphere formation and tumor growth in vivo, and resistance to chemotherapeutics and irradiation. Stemness is maintained by keeping levels of reactive oxygen species (ROS) low, which is achieved by enhanced activity of antioxidant pathways. Here, cellular sources of ROS, antioxidant pathways employed by CSCs, and underlying mechanisms to overcome resistance are discussed.

Citing Articles

Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction.

Verona F, Di Bella S, Schirano R, Manfredi C, Angeloro F, Bozzari G Front Immunol. 2025; 16:1529847.

PMID: 39981232 PMC: 11839637. DOI: 10.3389/fimmu.2025.1529847.

Targeted intracellular delivery of molecular cargo to hypoxic human breast cancer stem cells.

Makela A, Tundo A, Liu H, Schneider D, Hermiston T, Khodakivskyi P bioRxiv. 2024; .

PMID: 39605477 PMC: 11601403. DOI: 10.1101/2024.01.12.575071.

Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Yavorska M, Tomaciello M, Sciurti A, Cinelli E, Rubino G, Perrella A J Neurooncol. 2024; 170(3):611-618.

PMID: 39259411 PMC: 11615094. DOI: 10.1007/s11060-024-04818-9.

Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments.

Richter S, Steenblock C, Fischer A, Lemm S, Ziegler C, Bechmann N Theranostics. 2024; 14(1):17-32.

PMID: 38164150 PMC: 10750207. DOI: 10.7150/thno.87345.

Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells.

Farahzadi R, Valipour B, Fathi E, Pirmoradi S, Molavi O, Montazersaheb S Stem Cell Res Ther. 2023; 14(1):342.

PMID: 38017510 PMC: 10685711. DOI: 10.1186/s13287-023-03571-6.

References

Xiong B, Ma L, Hu X, Zhang C, Cheng Y . Characterization of side population cells isolated from the colon cancer cell line SW480. Int J Oncol. 2014; 45(3):1175-83. DOI: 10.3892/ijo.2014.2498. View

Szotek P, Pieretti-Vanmarcke R, Masiakos P, Dinulescu D, Connolly D, Foster R . Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A. 2006; 103(30):11154-9. PMC: 1544057. DOI: 10.1073/pnas.0603672103. View

Noman A, Parag R, Rashid M, Rahman M, Chowdhury A, Sultana A . Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer. Ther Adv Med Oncol. 2020; 12:1758835920911229. PMC: 7074584. DOI: 10.1177/1758835920911229. View

Afify S, Seno M . Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation. Cancers (Basel). 2019; 11(3). PMC: 6468812. DOI: 10.3390/cancers11030345. View

Li B, Cao Y, Meng G, Qian L, Xu T, Yan C . Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. EBioMedicine. 2018; 39:239-254. PMC: 6355660. DOI: 10.1016/j.ebiom.2018.11.063. View

Ryoo I, Choi B, Ku S, Kwak M . High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance. Redox Biol. 2018; 17:246-258. PMC: 6006726. DOI: 10.1016/j.redox.2018.04.015. View

Boesch M, Zeimet A, Fiegl H, Wolf B, Huber J, Klocker H . High prevalence of side population in human cancer cell lines. Oncoscience. 2016; 3(3-4):85-87. PMC: 4872646. DOI: 10.18632/oncoscience.300. View

Dengler V, Galbraith M, Espinosa J . Transcriptional regulation by hypoxia inducible factors. Crit Rev Biochem Mol Biol. 2013; 49(1):1-15. PMC: 4342852. DOI: 10.3109/10409238.2013.838205. View

Goto S, Kawabata T, Li T . Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance. Stem Cells Int. 2020; 2020:8868849. PMC: 7441449. DOI: 10.1155/2020/8868849. View

10.

Sies H, Jones D . Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020; 21(7):363-383. DOI: 10.1038/s41580-020-0230-3. View

11.

Castelli G, Pelosi E, Testa U . Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Cancers (Basel). 2017; 9(9). PMC: 5615342. DOI: 10.3390/cancers9090127. View

12.

Chang Q, Bi Z, Fu Y, Rice M, Zhang Q, Wadgaonkar P . Characterization of Arsenic-Induced Cancer Stem-Like Cells. Methods Mol Biol. 2020; 2117:293-303. DOI: 10.1007/978-1-0716-0301-7_19. View

13.

Engblom C, Pfirschke C, Pittet M . The role of myeloid cells in cancer therapies. Nat Rev Cancer. 2016; 16(7):447-62. DOI: 10.1038/nrc.2016.54. View

14.

Charles N, Ozawa T, Squatrito M, Bleau A, Brennan C, Hambardzumyan D . Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 2010; 6(2):141-52. PMC: 3818090. DOI: 10.1016/j.stem.2010.01.001. View

15.

Di Magno L, Manzi D, DAmico D, Coni S, Macone A, Infante P . Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth. Cell Cycle. 2014; 13(21):3404-13. PMC: 4613849. DOI: 10.4161/15384101.2014.952973. View

16.

Xu M, Li X, Liu T, Leng A, Zhang G . Prognostic value of hedgehog signaling pathway in patients with colon cancer. Med Oncol. 2011; 29(2):1010-6. DOI: 10.1007/s12032-011-9899-7. View

17.

Sun L, Zhang L, Chen J, Li C, Sun H, Wang J . Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma. Cancer Res Treat. 2020; 52(2):604-621. PMC: 7176959. DOI: 10.4143/crt.2019.444. View

18.

Wolke C, Antileo E, Lendeckel U . WNT signaling in atrial fibrillation. Exp Biol Med (Maywood). 2021; 246(9):1112-1120. PMC: 8113736. DOI: 10.1177/1535370221994086. View

19.

Tebay L, Robertson H, Durant S, Vitale S, Penning T, Dinkova-Kostova A . Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 2015; 88(Pt B):108-146. PMC: 4659505. DOI: 10.1016/j.freeradbiomed.2015.06.021. View

20.

Xing F, Hu Q, Qin Y, Xu J, Zhang B, Yu X . The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. Front Oncol. 2022; 12:862743. PMC: 9072740. DOI: 10.3389/fonc.2022.862743. View